Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
Nature Communications|April 21, 2025
High-temperature ferrimagnetic order triggered metal-to-insulator transition in CaCu3Ni2Os2O12Xubin Ye, Yunyu Yin, Yingying Cao, et al.
International Journal of Cardiology|November 16, 2024
Clinical impact of genetic testing in a large cohort of pediatric cardiomyopathiesFlavie Ader, Neil Derridj, Anne Claire Brehin, et al.
Trials|March 4, 2020
Study protocol for a randomized controlled trial: prophylactic swallowing exercises in head-and-neck cancer patients treated with (chemo)radiotherapy (PRESTO trial)Margot Baudelet, Leen Van den Steen, Fréderic Duprez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2021
Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451Taofeek K Owonikoko, Keunchil Park, Ramaswamy Govindan, et al.
Journal of the American Chemical Society|February 22, 2020
Sequential Spin State Transition and Intermetallic Charge Transfer in PbCoO3Zhehong Liu, Yuki Sakai, Junye Yang, et al.
The New England Journal of Medicine|June 2, 2015
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung CancerJulie Brahmer, Karen L Reckamp, Paul Baas, et al.
Dysphagia|September 19, 2022
Increasing Adherence to Prophylactic Swallowing Exercises During Head and Neck Radiotherapy: The Multicenter, Randomized Controlled PRESTO-TrialMargot Baudelet, Fréderic Duprez, Leen Van den Steen, et al.
Autoimmunity Reviews|March 13, 2026
Clinical characteristics and cancer risk of anti-OJ antisynthetase syndrome: A cohort comparative study and a systematic literature reviewValentin Pillot, Segolene Toquet, Jean Luc Charuel, et al.
Nature Communications|March 14, 2026
Hypusination of the translation factor eIF5A regulates mitochondrial tRNA processing to promote prostate cancer aggressivenessMichel Kahi, Abigail Mazzu, Ludovic Batistic, et al.
The Lancet. Oncology|February 24, 2015
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trialNaiyer A Rizvi, Julien Mazières, David Planchard, et al.
Pageof 17